Skip to main content
Top
Published in: Clinical Research in Cardiology 4/2015

01-04-2015 | Original Paper

Analyses of drugs stored at home by elderly patients with chronic heart failure

Authors: Sebastian Ewen, Tanja Baumgarten, Volker Rettig-Ewen, Felix Mahfoud, Nina Griese-Mammen, Martin Schulz, Michael Böhm, Ulrich Laufs

Published in: Clinical Research in Cardiology | Issue 4/2015

Login to get access

Abstract

Background

Evidence-based pharmacotherapy improves morbidity and mortality in patients with chronic heart failure (CHF). Medication adherence management is important for the effectiveness and safety of treatment. This study investigated drugs stored at home by elderly CHF patients.

Methods and results

One hundred and one patients with stable CHF age ≥65 years were visited at home where a standardized interview and a thorough assessment of medication were performed. Mean age of the patients was 77.7 ± 6.1 years, 53 % male, mean NYHA functional class of 2.8 ± 0.7 and a Minnesota-Living-with-Heart-Failure score of 59.4 ± 28.6 points indicating reduced quality of life. The mean number of different drug packs per patient was 13.1 ± 5.5, corresponding to a mean indexed value per patient of €403 ± 48. Cardiovascular drugs accounted for 32 % of the packs. On average, 2.4 ± 3.2 packs contained medication that was not taken by the patient (18 % of the medication, mean indexed value €61 ± 8). Fifty-six percent of the unused drugs were prescribed by general practitioners, 23 % in the hospital, and 7 % by medical specialists and 14 % were over-the-counter drugs. Sixty-three packages (5 %) of the drugs at home were expired (mean indexed value per patient €12 ± 3).

Conclusion

On average, elderly patients with CHF have to manage 13 different drug packs per day at home of which a significant portion is not taken as prescribed. New strategies are needed to support medicines management at home.
Literature
2.
go back to reference McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847. doi:10.1093/eurheartj/ehs104 CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847. doi:10.​1093/​eurheartj/​ehs104 CrossRefPubMed
5.
go back to reference De Geest S, Sabate E (2003) Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2(4):323CrossRefPubMed De Geest S, Sabate E (2003) Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs 2(4):323CrossRefPubMed
8.
go back to reference Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23(8):1296–1310CrossRefPubMed Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23(8):1296–1310CrossRefPubMed
9.
go back to reference Ambardekar AV, Fonarow GC, Hernandez AF et al (2009) Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from get with the guidelines-heart failure (GWTG-HF). Am Heart J 158(4):644–652. doi:10.1016/j.ahj.2009.07.034 CrossRefPubMed Ambardekar AV, Fonarow GC, Hernandez AF et al (2009) Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from get with the guidelines-heart failure (GWTG-HF). Am Heart J 158(4):644–652. doi:10.​1016/​j.​ahj.​2009.​07.​034 CrossRefPubMed
10.
go back to reference Michalsen A, Konig G, Thimme W (1998) Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80(5):437–441CrossRefPubMedCentralPubMed Michalsen A, Konig G, Thimme W (1998) Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80(5):437–441CrossRefPubMedCentralPubMed
11.
go back to reference Böhm M, Schumacher H, Laufs U et al (2013) Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. Am Heart J 166(2):306–314.e307. doi:10.1016/j.ahj.2013.04.016 Böhm M, Schumacher H, Laufs U et al (2013) Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. Am Heart J 166(2):306–314.e307. doi:10.​1016/​j.​ahj.​2013.​04.​016
12.
go back to reference Granger BB, Swedberg K, Ekman I et al (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366(9502):2005–2011. doi:10.1016/s0140-6736(05)67760-4 CrossRefPubMed Granger BB, Swedberg K, Ekman I et al (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366(9502):2005–2011. doi:10.​1016/​s0140-6736(05)67760-4 CrossRefPubMed
13.
go back to reference Gorenoi V, Schonermark MP, Hagen A (2008) Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes. GMS Health Technol Assess 3:Doc14 Gorenoi V, Schonermark MP, Hagen A (2008) Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes. GMS Health Technol Assess 3:Doc14
14.
go back to reference Esposito D, Bagchi AD, Verdier JM et al (2009) Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care 15(7):437–445PubMed Esposito D, Bagchi AD, Verdier JM et al (2009) Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care 15(7):437–445PubMed
16.
go back to reference Montalescot G, Sechtem U et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003. doi:10.1093/eurheartj/eht296 CrossRefPubMed Montalescot G, Sechtem U et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003. doi:10.​1093/​eurheartj/​eht296 CrossRefPubMed
17.
go back to reference Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
20.
go back to reference Rector TS, Cohn JN (1992) Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124(4):1017–1025CrossRefPubMed Rector TS, Cohn JN (1992) Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124(4):1017–1025CrossRefPubMed
23.
go back to reference Stanley M, Prasun M (2002) Heart failure in older adults: keys to successful management. AACN Clin Issues 13(1):94–102CrossRefPubMed Stanley M, Prasun M (2002) Heart failure in older adults: keys to successful management. AACN Clin Issues 13(1):94–102CrossRefPubMed
25.
28.
go back to reference Miura T, Kojima R, Mizutani M et al (2001) Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol 57(1):77–83CrossRefPubMed Miura T, Kojima R, Mizutani M et al (2001) Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol 57(1):77–83CrossRefPubMed
29.
go back to reference Tebbe U, Tschope C, Wirtz JH et al (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol. doi:10.1007/s00392-014-0678-2 (published online) Tebbe U, Tschope C, Wirtz JH et al (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol. doi:10.​1007/​s00392-014-0678-2 (published online)
35.
go back to reference Braunstein JB, Anderson GF, Gerstenblith G et al (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7):1226–1233. doi:10.1016/s0735-1097(03)00947-1 CrossRefPubMed Braunstein JB, Anderson GF, Gerstenblith G et al (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7):1226–1233. doi:10.​1016/​s0735-1097(03)00947-1 CrossRefPubMed
36.
go back to reference Böhm M, Pogue J, Kindermann I et al (2014) Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure. Eur J Heart Fail 16(3):325–333. doi:10.1002/ejhf.23 CrossRefPubMed Böhm M, Pogue J, Kindermann I et al (2014) Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure. Eur J Heart Fail 16(3):325–333. doi:10.​1002/​ejhf.​23 CrossRefPubMed
40.
go back to reference Flesch M, Erdmann E (2006) The problem of polypharmacy in heart failure. Curr Cardiol Rep 8(3):217–225CrossRefPubMed Flesch M, Erdmann E (2006) The problem of polypharmacy in heart failure. Curr Cardiol Rep 8(3):217–225CrossRefPubMed
42.
go back to reference Kindermann I, Fischer D, Karbach J et al (2012) Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail 14(4):404–413. doi:10.1093/eurjhf/hfs015 CrossRefPubMed Kindermann I, Fischer D, Karbach J et al (2012) Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail 14(4):404–413. doi:10.​1093/​eurjhf/​hfs015 CrossRefPubMed
Metadata
Title
Analyses of drugs stored at home by elderly patients with chronic heart failure
Authors
Sebastian Ewen
Tanja Baumgarten
Volker Rettig-Ewen
Felix Mahfoud
Nina Griese-Mammen
Martin Schulz
Michael Böhm
Ulrich Laufs
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 4/2015
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-014-0783-2

Other articles of this Issue 4/2015

Clinical Research in Cardiology 4/2015 Go to the issue